A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV

NCT02138253 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Fibrosis
Hepatic Fibrosis
Liver Cirrhosis
Hepatic Cirrhosis

Interventions

DRUG: IDN-6556
DRUG: Placebo

Sponsor

Conatus Pharmaceuticals Inc.